Here, we show that novel 2-aryl-3-(4-adamantyl-thiazol-21,3-thiazolidin-4-one derivatives have a mixed- or fully competitive mechanism of inhibition towards HIV-1 Reverse Transcriptase with respect to the substrates of the reaction. Thus, they are interesting starting points for the development of novel NNRTIs with an uncommon mechanism of action.
在这里,我们证明新型 2-aryl-3-(4-adamantyl-thiazol-21,3-thiazolidin-4-one 衍
生物对于底物而言对 HIV-1 逆转录酶具有混合或完全竞争性抑制机制因此,它们是开发具有不常见作用机制的新型 NNRTI 的有趣起点。